Introduction {#sec1-1}
============

Inflammatory bowel disease (IBD) defines chronic conditions of which Crohn's disease and ulcerative colitis are the most predominant forms \[[@ref1],[@ref2]\]. These diseases generally start at a young age, affect the quality of life of both patients and their families, and cause a high level of healthcare resource consumption \[[@ref3]\]. A multidisciplinary approach provided by different professionals -- physicians, nurses, psychologists, and dieticians -- is advisable for an appropriate care of IBD patients \[[@ref4],[@ref5]\]. Among them, trained nurses play an important role \[[@ref6]-[@ref8]\]. The Nurses-European Crohn's & Colitis Organisation (N-ECCO) Consensus statements defined the basic and advanced nursing care ('Fundamental IBD Nurse' and 'Advanced IBD Nurse') required to address patients' needs \[[@ref9]\]. Shortly, IBD nurses involved in the basic nursing care should have basic knowledge on the diagnosis and therapy of IBD as well as how this illness affects health-related quality of life. They should develop an empathetic role towards IBD patients to favor communication on pain, fatigue or sexual concerns. Moreover, IBD nurses should collaborate with healthcare professionals in managing fistulas, stomas, fecal incontinence, and the nutritional status of patients. Therefore, both clinical experience and a specific training are required for IBD nurses. To date, the title -- as well as the level of training and/or education -- of IBD nurse is not formally recognized in Italy, even if the need for IBD basic and advanced nursing care has been recently underlined in an official document of National Health planning \[[@ref10]\].

The presence of IBD nurse in a multidisciplinary team is expected to be particularly relevant when managing those IBD patients receiving biological therapies due to a more severe disease \[[@ref11]\]. Indeed, these patients require a pre-therapy screening, strict follow up, scheduled controls, and facilities for unscheduled visits due to potential adverse events, and IBD nurses are actively involved in any of these processes. A recent N-ECCO survey of nursing practice in caring IBD patients in Europe demonstrated that the role of nurses does exist in various settings within hospital care, providing complex management and autonomous nursing care in a range of services \[[@ref6]\]. However, only few (n=4) nurses participated from Italy. Therefore, with the auspices of the ANOTE-ANIGEA (National Association of Endoscopic Techniques Operators -- National Association of Gastroenterology Nurses and Associates), we performed an Italian nationwide survey to assess the presence of IBD nurse in centers where patients receive biological therapies. As a secondary endpoint, the unmet needs for professional formation of these nurses were recorded.

Materials and methods {#sec1-2}
=====================

Questionnaire {#sec2-1}
-------------

A specific questionnaire was prepared to evaluate whether an IBD nurse was available in Italian centers providing biological therapies for IBD patients (Appendix, see online version). This included the following 3 parts: a) demographic data, general training, and degree (8 items); b) information on specific roles directly played in caring IBD patients on biological therapy (8 items); c) information on specific training for IBD nursing (7 items). The questionnaire also invited every nurse to write down which the unmet needs in the education process of an IBD nurse were.

A nurse involved in the administration of biologics was arbitrarily defined as IBD nurse when he/she was in charge of the following roles: a) organization of biological therapy (screening pre-therapy, appointments scheduling, and follow up); b) administration of biological therapy with monitoring during the infusion (infliximab) or patient's (or family) training for a correct subcutaneous injection (adalimumab); c) dedicated helpline with triage for accesses to the clinic during therapy; d) knowledge and observation of all N-ECCO Consensus statements for IBD \[[@ref9]\]; and e) attendance of a course specifically dedicated to biological treatment or a specific training by an experienced colleague.

Participants {#sec2-2}
------------

An invitation letter containing the survey protocol was sent by e-mail to all ANOTE-ANIGEA associates. In addition, when the contacted associate declined the participation or was lacking in a specific Italian region, at least another IBD center was contacted for an appropriate coverage of the national territory. Only nurses working in those IBD centers where at least 10 patients receiving biological therapies were invited to participate. Following acceptance and satisfaction of the inclusion criteria the questionnaire was sent by mail, and the filled documents were collected in a single center for data analysis. One repeat telephone call was performed when the reply of the participant was insufficient.

Data analysis {#sec2-3}
-------------

Data of all questionnaires were individually rowed into a computerized spreadsheet for statistical analysis. T- and chi-square tests were used as appropriate. A P value less than 0.05 was considered significant.

Results {#sec1-3}
=======

A total of 53 (72.6%) of 73 contacted centers participated in the survey, with a median of 2 (range: 1-14) participating centers per region. Overall, 93 questionnaires were received, with a median of 1 (range 1-5) from each center, but 2 of them containing incomplete data were excluded from the analysis. The demographic characteristics of the participants are given in [Table 1](#T1){ref-type="table"}.

###### 

Characteristics of participants
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According to the predefined criteria, a total of 34 (37.4%) nurses could be classified as IBD specialists. As shown in [Table 2](#T2){ref-type="table"}, IBD nurses had a significantly higher educational level than other nurses; they were more frequently operating in Central or Southern than in Northern Italy; they were working in an Academic center rather than in a General hospital and in IBD centers with \>25 patients on biological therapies. In addition, the length of service in a Gastroenterology Unit tended to be longer for an IBD nurse than other nurses, although the difference failed to reach statistical significance (12.1±8.3 vs. 9.7±6.5 years; P=0.053). On the contrary, mean age (47.8±7.2 vs. 46.9±5.6 years; P=0.8), gender distribution (M/F: 7/27 vs. 7/50; P=0.3), years of nursing (24.9±8.9 vs. 23.5.±6.4 years; P=0.6), and years working in the IBD unit (6.9±5.4 vs. 5.4±4.4 years; P=0.09) did not significantly differ between IBD and other nurses.

###### 

Differences between IBD nurses and other nurses
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A total of 49 (53.8%) nurses provided one or more information on unmet needs for their specific professional training. The most frequent requests were: 1) to perform a specific theoretical training for caring IBD patients (33 nurses, 67.4%); 2) to make a direct comparison of their nursing practice with that of other dedicated centers (15 nurses; 30.6%); and 3) to complete a specific practical training (5 nurses; 10.2%).

Discussion {#sec1-4}
==========

An appropriate care for IBD patients requires a multidisciplinary approach, particularly for those patients with a more severe disease necessitating biological therapies \[[@ref1],[@ref11]\]. Among different figures involved in such a team, the role of IBD nurse specialists is particularly relevant, since they can provide direct care as well as a holistic support \[[@ref12],[@ref13]\]. Although the role of IBD nurses in improving health outcomes remains to be proven \[[@ref14]\], there are increasing data supporting that they play a relevant role in some settings. For instance, they helpfully perform triage of IBD patients by a dedicated helpline. Indeed, IBD nurse specialists may provide appropriate and timely visits, with an obvious impact on both patients' satisfaction and use of health resources \[[@ref15],[@ref16]\]. In Europe, a formal IBD Nursing education is available in the UK, Austria, Czech Republic, Finland, Germany, The Netherlands, Spain and Sweden, and it is under development in Belgium and Denmark \[[@ref5]\], and, more recently, in Italy \[[@ref10]\]. In detail, the figure of both 'Fundamental IBD nurse' and 'Advanced IBD nurse' is delineated by the National Health System and by Italian College of Nursing \[[@ref10],[@ref17]\].

We evaluated the presence of IBD nurses actually managing those IBD patients receiving biological therapies. Overall, the data of our nationwide survey show that less than 40% of IBD centers providing biological therapies can rely on an IBD nurse. Interestingly, we found that IBD nurses have a higher educational level and a longer experience in Gastroenterology Unit than non-dedicated nurses. Moreover, from our survey emerged that IBD are less frequently present in General Hospitals and in low-volume centers. All these observations suggest that the presence of IBD nurses needs to be implemented in Italy, particularly in low-volume centers and in non-academic Hospitals. Indeed, IBD patients on biological therapies should receive the same high-quality level of nursing, irrespective of the total number of patients managed. The lacking of IBD nurses in several Italian centers appears even more disappointing considering that in other countries even the role of Clinical Nurse Specialist is already recognized not only for IBD \[[@ref12],[@ref13],[@ref18]\], but also for diabetes, heart failure, rheumatology, etc. \[[@ref19],[@ref20]\]. The IBD Clinical Nurse Specialist (or Advanced IBD Nurse) provides an advanced level of care with regard to IBD, and such a nursing stage is achieved only following a combination of extensive clinical practice, professional development and formal education (honors degree or master) \[[@ref9],[@ref12],[@ref13]\]. In the UK, the number of IBD nurse specialists doubled in the IBD Service Provision between 2006 and 2010, suggesting a real need of such a figure \[[@ref21]\].

Another relevant finding of this survey is that more than half of the nurses currently caring for IBD patients receiving biological therapies in Italy express the need for more theoretical and practical specialized training, suggesting that implementation of training in IBD nursing is largely required in our country. Contrary to the physicians, to gain funding to perform courses is not easy for nurses, as well as to obtain time away from clinical practice are often not considered high priority by Departments \[[@ref12]\]. Therefore, we would suggest that all the organizations potentially involved in nurse teaching (Departments, Scientific Societies, National Patient Support Associations, etc.) should be aware of these difficulties and should encourage the nurses' professional education.

In conclusion, our nationwide survey showed that the presence of an IBD nurse is still lacking in the majority of Italian IBD centers where patients receive biological therapies, suggesting a prompt implementation.

###### Summary Box

**What is already known:**

Management of inflammatory bowel disease (IBD) patients on biological therapies requires a multidisciplinary approachThere are increasing data supporting that dedicated nurses play a relevant role in this settingA formal IBD Nursing education is available in different European countries, but not in Italy

**What the new findings are:**

This Italian nationwide survey showed that less than 40% of IBD centers providing biological therapies rely on an IBD nurseMore than half of the nurses currently caring for IBD patients receiving biological therapies expressed the need for theoretical and practical specialized training, suggesting that implementation of training in IBD nursing is largely required in Italy
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